High bone mineral density in sickle cell disease: Prevalence and characteristics. 2018

Gonzalo De Luna, and Brigitte Ranque, and Marie Courbebaisse, and Jean-Antoine Ribeil, and Djamal Khimoud, and Sidonie Dupeux, and Jonathan Silvera, and Lucile Offredo, and Jacques Pouchot, and Jean-Benoît Arlet
Internal Medicine Department, Sickle Cell Referral Center, Georges Pompidou European Hospital, AP-HP, Paris, France; Faculté de Médecine Paris Descartes, Sorbonne Paris-Cité, Paris, France. Electronic address: gonzalo.deluna@aphp.fr.

Osteosclerosis (OSC) is a rarely studied complication of sickle cell disease (SCD). The objective of our study was to determine the prevalence and characteristics of high bone mineral density (BMD) and its radiological features in adult SCD patients. This prospective observational study was conducted from May 2007 to May 2016 in consecutive patients with steady-state SCD at two university hospitals. The BMD of the lumbar spine (L1-L4) and right femoral neck was determined by dual energy X-ray absorptiometry. Clinical, laboratory and radiographic data were recorded. High BMD was defined as a BMD Z-score of at least +2.5 standard deviations at the lumbar spine or hip. The characteristics of the patients with high BMD were compared to those of individuals with low or middle BMD, using multivariate ordinal logistic regression. 135 patients (86 women and 49 men) with a median age of 27 (IQR 23-33) years were included. High BMD was diagnosed in 20 (15%) patients with a median age of 33.5 (IQR 28-45) years. The SCD genotypes of these patients were SS in 11, SC in 5, S/beta+ in 3, and S/beta0 in 1. High BMD patients more frequently harbored the S/beta SCD genotype (21% vs 5% in non-high BMD patients; p=0.047) and were older (p=0.0007). Compared to patients with low or middle BMD, after adjustment for age and SCD genotype, high BMD patients had a higher prevalence of avascular necrosis history (p=0.009), higher BMI (p=0.007), and lower serum resorption marker CTX (p=0.04), bilirubin (p=0.02) and parathyroid hormone levels (p=0.02). There were no differences between groups regarding fracture history, H-shaped vertebrae or other biological variables. High-BMD values is a common manifestation in SCD patients, especially in those with the S/beta-thalassemia genotypes. The prevalence of high-BMD in SCD is associated with older age, suggesting that it will be more common in the future because the life span of patients with SCD is increasing thanks to significant progress in SCD treatment.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000755 Anemia, Sickle Cell A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S. Hemoglobin S Disease,HbS Disease,Sickle Cell Anemia,Sickle Cell Disease,Sickle Cell Disorders,Sickling Disorder Due to Hemoglobin S,Anemias, Sickle Cell,Cell Disease, Sickle,Cell Diseases, Sickle,Cell Disorder, Sickle,Cell Disorders, Sickle,Disease, Hemoglobin S,Hemoglobin S Diseases,Sickle Cell Anemias,Sickle Cell Diseases,Sickle Cell Disorder
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D015519 Bone Density The amount of mineral per square centimeter of BONE. This is the definition used in clinical practice. Actual bone density would be expressed in grams per milliliter. It is most frequently measured by X-RAY ABSORPTIOMETRY or TOMOGRAPHY, X RAY COMPUTED. Bone density is an important predictor for OSTEOPOROSIS. Bone Mineral Content,Bone Mineral Density,Bone Densities,Bone Mineral Contents,Bone Mineral Densities,Density, Bone,Density, Bone Mineral
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

Gonzalo De Luna, and Brigitte Ranque, and Marie Courbebaisse, and Jean-Antoine Ribeil, and Djamal Khimoud, and Sidonie Dupeux, and Jonathan Silvera, and Lucile Offredo, and Jacques Pouchot, and Jean-Benoît Arlet
April 2006, American journal of hematology,
Gonzalo De Luna, and Brigitte Ranque, and Marie Courbebaisse, and Jean-Antoine Ribeil, and Djamal Khimoud, and Sidonie Dupeux, and Jonathan Silvera, and Lucile Offredo, and Jacques Pouchot, and Jean-Benoît Arlet
January 2024, Bone,
Gonzalo De Luna, and Brigitte Ranque, and Marie Courbebaisse, and Jean-Antoine Ribeil, and Djamal Khimoud, and Sidonie Dupeux, and Jonathan Silvera, and Lucile Offredo, and Jacques Pouchot, and Jean-Benoît Arlet
April 2015, Anales de pediatria (Barcelona, Spain : 2003),
Gonzalo De Luna, and Brigitte Ranque, and Marie Courbebaisse, and Jean-Antoine Ribeil, and Djamal Khimoud, and Sidonie Dupeux, and Jonathan Silvera, and Lucile Offredo, and Jacques Pouchot, and Jean-Benoît Arlet
January 2010, Acta haematologica,
Gonzalo De Luna, and Brigitte Ranque, and Marie Courbebaisse, and Jean-Antoine Ribeil, and Djamal Khimoud, and Sidonie Dupeux, and Jonathan Silvera, and Lucile Offredo, and Jacques Pouchot, and Jean-Benoît Arlet
December 2006, Pediatric blood & cancer,
Gonzalo De Luna, and Brigitte Ranque, and Marie Courbebaisse, and Jean-Antoine Ribeil, and Djamal Khimoud, and Sidonie Dupeux, and Jonathan Silvera, and Lucile Offredo, and Jacques Pouchot, and Jean-Benoît Arlet
November 1973, British journal of haematology,
Gonzalo De Luna, and Brigitte Ranque, and Marie Courbebaisse, and Jean-Antoine Ribeil, and Djamal Khimoud, and Sidonie Dupeux, and Jonathan Silvera, and Lucile Offredo, and Jacques Pouchot, and Jean-Benoît Arlet
April 2014, The American journal of the medical sciences,
Gonzalo De Luna, and Brigitte Ranque, and Marie Courbebaisse, and Jean-Antoine Ribeil, and Djamal Khimoud, and Sidonie Dupeux, and Jonathan Silvera, and Lucile Offredo, and Jacques Pouchot, and Jean-Benoît Arlet
March 2018, Hemoglobin,
Gonzalo De Luna, and Brigitte Ranque, and Marie Courbebaisse, and Jean-Antoine Ribeil, and Djamal Khimoud, and Sidonie Dupeux, and Jonathan Silvera, and Lucile Offredo, and Jacques Pouchot, and Jean-Benoît Arlet
September 1999, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR),
Gonzalo De Luna, and Brigitte Ranque, and Marie Courbebaisse, and Jean-Antoine Ribeil, and Djamal Khimoud, and Sidonie Dupeux, and Jonathan Silvera, and Lucile Offredo, and Jacques Pouchot, and Jean-Benoît Arlet
January 2022, Journal of pediatric hematology/oncology,
Copied contents to your clipboard!